| Medicines are made of harmful chemicals and | | | | these plants focus more on production of antibodies |
| components extracted from animal origin. But it could | | | | and therapeutic proteins from genetically engineered |
| be very fatal and full of side effects. Hence, | | | | plants. These salutary proteins are used in the |
| Biotechnology has developed genetically engineered | | | | treatment of many lethal diseases like cancer, |
| plants that contains healing capacities and can cure | | | | leukemia, immunity disorders and several infections. |
| crucial diseases without any side-effects. These | | | | The use of genetically altered plants in |
| plants are used to develop medicines in | | | | biotechnological plants offers several advantages. |
| biotechnological plants. | | | | They are capable of meeting the huge demand of |
| Since long, living organisms like yeasts and bacterias | | | | pharmaceuticals in the market. Also the medicines |
| have been utilized as the resources for development | | | | produced by them are cost-effective that can be |
| of pharmaceuticals. These resources are not | | | | affordable by everyone. They involve flexible and |
| sufficient to meet the growing requirements. | | | | easy methods of production. The additional benefit |
| Therefore to solve this problem, now plants are used | | | | these plants get is that the cell structure of plants is |
| as alternatives to animal resources. Several pharmacy | | | | very similar to animals. |
| plants have already been cultured in numerous | | | | However, the agriculture of pharmacy plants |
| countries and are at their development stages. Soya, | | | | introduces various safety challenges. Genetically |
| tobacco, oilseed and maize are some of the | | | | engineered plants can mix with the food crops and |
| pharmacy crops which have been used for trial. | | | | other eatables and can be very dangerous. Hence, |
| Biotechnological plants have enormous capacity to | | | | numerous safety measures are taken into account |
| manufacture pharmaceutical products like | | | | and augmented use of non-food crops to decrease |
| blood-clotting proteins, vaccines, antibodies, growth | | | | the risks is well practiced in medicine manufacturing |
| hormones, structural substances including collagen, | | | | plants of these biopharmaceuticals. |
| anti-viral, antimicrobial and various enzymes. However, | | | | |